{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:42:58Z","timestamp":1740141778647,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["SFRH\/BD\/69062\/2010"],"award-info":[{"award-number":["SFRH\/BD\/69062\/2010"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PEst-OE\/SAU\/UI4013\/2014"],"award-info":[{"award-number":["PEst-OE\/SAU\/UI4013\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11306-016-1091-9","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:46:41Z","timestamp":1470271601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transient decrease of hepatic NAD+ and amino acid alterations during treatment with\u00a0valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics"],"prefix":"10.1007","volume":"12","author":[{"given":"Marco F.","family":"Moedas","sequence":"first","affiliation":[]},{"given":"Arno G.","family":"van Cruchten","sequence":"additional","affiliation":[]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[]},{"given":"Wim","family":"Kulik","sequence":"additional","affiliation":[]},{"given":"Isabel Tavares","family":"de Almeida","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Diogo","sequence":"additional","affiliation":[]},{"given":"Ronald J. A.","family":"Wanders","sequence":"additional","affiliation":[]},{"given":"Margarida F. B.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"issue":"5","key":"1091_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","volume":"79","author":"CCP Aires","year":"2010","unstructured":"Aires, C. C. P., IJlst, L., Stet, F., Prip-Buus, C., de Almeida, I. T., Duran, M., et al. (2010). Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochemical Pharmacology, 79(5), 792\u2013799. doi: 10.1016\/j.bcp.2009.10.011 .","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"1091_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jhep.2010.11.031","volume":"55","author":"CCP Aires","year":"2011","unstructured":"Aires, C. C. P., van Cruchten, A., IJlst, L., de Almeida, I. T., Duran, M., Wanders, R. J. A., et al. (2011). New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. Journal of Hepatology, 55(2), 426\u2013434. doi: 10.1016\/j.jhep.2010.11.031 .","journal-title":"Journal of Hepatology"},{"issue":"4","key":"1091_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai, P., Cant\u00f3, C., Oudart, H., Bruny\u00e1nszki, A., Cen, Y., Thomas, C., et al. (2011). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metabolism, 13(4), 461\u2013468. doi: 10.1016\/j.cmet.2011.03.004 .","journal-title":"Cell Metabolism"},{"issue":"4","key":"1091_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011). Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. Journal of Hepatology, 54(4), 773\u2013794. doi: 10.1016\/j.jhep.2010.11.006 .","journal-title":"Journal of Hepatology"},{"issue":"6","key":"1091_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s11306-015-0831-6","volume":"11","author":"VJ Bhute","year":"2015","unstructured":"Bhute, V. J., & Palecek, S. P. (2015). Metabolic responses induced by DNA damage and poly (ADP-ribose) polymerase (PARP) inhibition in MCF-7 cells. Metabolomics, 11(6), 1779\u20131791. doi: 10.1007\/s11306-015-0831-6 .","journal-title":"Metabolomics"},{"issue":"4","key":"1091_CR6","doi-asserted-by":"publisher","first-page":"e19194","DOI":"10.1371\/journal.pone.0019194","volume":"6","author":"N Braidy","year":"2011","unstructured":"Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011). Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One, 6(4), e19194. doi: 10.1371\/journal.pone.0019194 .","journal-title":"PLoS One"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"D1251","DOI":"10.1093\/nar\/gkv1003","volume":"44","author":"SE Calvo","year":"2016","unstructured":"Calvo, S. E., Clauser, K. R., & Mootha, V. K. (2016). MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Research, 44, D1251\u2013D1257. doi: 10.1093\/nar\/gkv1003 .","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"1091_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/pr.110.003905","volume":"64","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3, C., & Auwerx, J. (2012). Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacological Reviews, 64(1), 166\u2013187. doi: 10.1124\/pr.110.003905 .","journal-title":"Pharmacological Reviews"},{"issue":"7241","key":"1091_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., et al. (2009). AMPK regulates energy expenditure by modulating NAD+metabolism and SIRT1 activity. Nature, 458(7241), 1056\u20131060. doi: 10.1038\/nature07813 .","journal-title":"Nature"},{"issue":"6","key":"1091_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., et al. (2012). The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism, 15(6), 838\u2013847. doi: 10.1016\/j.cmet.2012.04.022 .","journal-title":"Cell Metabolism"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrc3985","volume":"15","author":"A Chalkiadaki","year":"2015","unstructured":"Chalkiadaki, A., & Guarente, L. (2015). The multifaceted functions of sirtuins in cancer. Nature\u00a0Reviews Cancer, 15, 608\u2013624. doi: 10.1038\/nrc3985 .","journal-title":"Nature\u00a0Reviews Cancer"},{"issue":"2","key":"1091_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","volume":"63","author":"M Chen","year":"2015","unstructured":"Chen, M., Suzuki, A., Borlak, J., Andrade, R. J., & Lucena, M. I. (2015). Drug-induced liver injury: Interactions between drug properties and host factors. Journal of Hepatology, 63(2), 503\u2013514. doi: 10.1016\/j.jhep.2015.04.016 .","journal-title":"Journal of Hepatology"},{"issue":"12","key":"1091_CR13","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1517\/13543784.2013.853037","volume":"22","author":"L \u010cin\u010d\u00e1rov\u00e1","year":"2013","unstructured":"\u010cin\u010d\u00e1rov\u00e1, L., Zdr\u00e1hal, Z., & Fajkus, J. (2013). New perspectives of valproic acid in clinical practice. Expert Opinion on Iinvestigational Drugs, 22(12), 1535\u20131547. doi: 10.1517\/13543784.2013.853037 .","journal-title":"Expert Opinion on Iinvestigational Drugs"},{"issue":"1","key":"1091_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1476-4598-7-70","volume":"7","author":"M Dejligbjerg","year":"2008","unstructured":"Dejligbjerg, M., Grauslund, M., Litman, T., Collins, L., Qian, X., Jeffers, M., et al. (2008). Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. Molecular Cancer, 7(1), 70. doi: 10.1186\/1476-4598-7-70 .","journal-title":"Molecular Cancer"},{"key":"1091_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-540-76698-8_5","volume-title":"Laboratory guide to the methods in biochemical genetics","author":"M Duran","year":"2008","unstructured":"Duran, M. (2008). Amino acids. In N. Blau, M. Duran, & K. M. Gibson (Eds.), Laboratory guide to the methods in biochemical genetics (pp. 53\u201389). Berlin: Springer. doi: 10.1007\/978-3-540-76698-8_5 ."},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6769-10-2","volume":"10","author":"C Evans","year":"2010","unstructured":"Evans, C., Bogan, K. L., Song, P., Burant, C. F., Kennedy, R. T., & Brenner, C. (2010). NAD\u00a0+\u00a0metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity. BMC Chemical Biology, 10, 2. doi: 10.1186\/1472-6769-10-2 .","journal-title":"BMC Chemical Biology"},{"issue":"9","key":"1091_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg, K. J., & Johnstone, R. W. (2014). Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nature Reviews in Drug Discovery, 13(9), 673\u2013691. doi: 10.1038\/nrd4360 .","journal-title":"Nature Reviews in Drug Discovery"},{"issue":"2","key":"1091_CR17","first-page":"132","volume":"3","author":"SA Fischkoff","year":"1984","unstructured":"Fischkoff, S. A., & Walter, E. J. (1984). Induction of neutrophilic differentiation of human promyelocytic leukemic cells by branched-chain carboxylic acid anticonvulsant drugs. Journal of Biological Response Modifiers, 3(2), 132\u2013137.","journal-title":"Journal of Biological Response Modifiers"},{"key":"1091_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28245","author":"K Gariani","year":"2015","unstructured":"Gariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., et al. (2015). Eliciting the mitochondrial unfolded protein response via NAD+ repletion reverses fatty liver disease. Hepatology. doi: 10.1002\/hep.28245 .","journal-title":"Hepatology"},{"issue":"3","key":"1091_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","volume":"64","author":"N Gurvich","year":"2004","unstructured":"Gurvich, N., Tsygankova, O. M., Meinkoth, J. L., & Klein, P. S. (2004). Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Research, 64(3), 1079\u20131086. doi: 10.1158\/0008-5472.CAN-03-0799 .","journal-title":"Cancer Research"},{"issue":"2","key":"1091_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.molcel.2011.01.002","volume":"41","author":"WC Hallows","year":"2011","unstructured":"Hallows, W. C., Yu, W., Smith, B. C., Devries, M. K., Ellinger, J. J., Someya, S., et al. (2011). Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Molecular Cell, 41(2), 139\u2013149. doi: 10.1016\/j.molcel.2011.01.002 .","journal-title":"Molecular Cell"},{"issue":"6","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/cr.2013.70","volume":"23","author":"AZ Herskovits","year":"2013","unstructured":"Herskovits, A. Z., & Guarente, L. (2013). Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Research, 23(6), 746\u2013758. doi: 10.1038\/cr.2013.70 .","journal-title":"Cell Research"},{"issue":"7285","key":"1091_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature08778","volume":"464","author":"MD Hirschey","year":"2010","unstructured":"Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464(7285), 121\u2013125. doi: 10.1038\/nature08778 .","journal-title":"Nature"},{"issue":"18","key":"1091_CR23","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1093\/hmg\/ddu218","volume":"23","author":"SM Houten","year":"2014","unstructured":"Houten, S. M., Denis, S., te Brinke, H., Jongejan, A., van Kampen, A. H. C., Bradley, E. J., et al. (2014). Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. Human Molecular Genetics, 23(18), 5009\u20135016. doi: 10.1093\/hmg\/ddu218 .","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"1091_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1210\/er.2009-0026","volume":"31","author":"RH Houtkooper","year":"2010","unstructured":"Houtkooper, R. H., Cant\u00f3, C., Wanders, R. J., & Auwerx, J. (2010). The secret life of NAD+: An old metabolite controlling new metabolic signaling pathways. Endocrine Reviews, 31(2), 194\u2013223. doi: 10.1210\/er.2009-0026 .","journal-title":"Endocrine Reviews"},{"issue":"S3","key":"1091_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/dom.12171","volume":"15","author":"S Imai","year":"2013","unstructured":"Imai, S., & Yoshino, J. (2013). The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes, Obesity and Metabolism, 15(S3), 26\u201333. doi: 10.1111\/dom.12171 .","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2183\/pjab.84.246","volume":"84","author":"G Kikuchi","year":"2008","unstructured":"Kikuchi, G., Motokawa, Y., Yoshida, T., & Hiraga, K. (2008). Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proceedings of the Japan Academy Series B, Physical and Biological Sciences, 84, 246\u2013263. doi: 10.2183\/pjab.84.246 .","journal-title":"Proceedings of the Japan Academy Series B, Physical and Biological Sciences"},{"issue":"2","key":"1091_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/pr100892r","volume":"10","author":"H-J Kim","year":"2011","unstructured":"Kim, H.-J., Kim, J. H., Noh, S., Hur, H. J., Sung, M. J., Hwang, J.-T., et al. (2011). Metabolomic analysis of livers and serum from high-fat diet induced obese mice. Journal of Proteome Research, 10(2), 722\u2013731. doi: 10.1021\/pr100892r .","journal-title":"Journal of Proteome Research"},{"issue":"2","key":"1091_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-3223(85)90085-X","volume":"20","author":"GN Ko","year":"1985","unstructured":"Ko, G. N., Korpi, E. R., Freed, W. J., Zalcman, S. J., & Bigelow, L. B. (1985). Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients. Biological Psychiatry, 20(2), 209\u2013215.","journal-title":"Biological Psychiatry"},{"issue":"2","key":"1091_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jchromb.2008.04.031","volume":"871","author":"W Lu","year":"2008","unstructured":"Lu, W., Bennett, B. D., & Rabinowitz, J. D. (2008). Analytical strategies for LC\u2013MS-based targeted metabolomics. Journal of Chromatography B, 871(2), 236\u2013242. doi: 10.1016\/j.jchromb.2008.04.031 .","journal-title":"Journal of Chromatography B"},{"issue":"9","key":"1091_CR30","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbabio.2007.06.007","volume":"1767","author":"PBM Lu\u00eds","year":"2007","unstructured":"Lu\u00eds, P. B. M., Ruiter, J. P. N., Aires, C. C. P., Soveral, G., Tavares de Almeida, I., Duran, M., et al. (2007). Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation. Biochimica et Biophysica Acta (BBA) Bioenergetics, 1767(9), 1126\u20131133. doi: 10.1016\/j.bbabio.2007.06.007 .","journal-title":"Biochimica et Biophysica Acta (BBA) Bioenergetics"},{"issue":"7","key":"1091_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1124\/dmd.110.037606","volume":"39","author":"PBM Luis","year":"2011","unstructured":"Luis, P. B. M., Ruiter, J. P. N., IJlst, L., de Almeida, I. T., Duran, M., Mohsen, A. W., et al. (2011). Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway. Drug Metabolism and Disposition, 39(7), 1155\u20131160. doi: 10.1124\/dmd.110.037606 .","journal-title":"Drug Metabolism and Disposition"},{"issue":"11","key":"1091_CR32","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bcp.2011.07.103","volume":"82","author":"PBM Lu\u00eds","year":"2011","unstructured":"Lu\u00eds, P. B. M., Ruiter, J. P., Ofman, R., IJlst, L., Moedas, M., Diogo, L., et al. (2011). Valproic acid utilizes the isoleucine breakdown pathway for its complete \u03b2-oxidation. Biochemical Pharmacology, 82(11), 1740\u20131746. doi: 10.1016\/j.bcp.2011.07.103 .","journal-title":"Biochemical Pharmacology"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuroscience.2012.12.052","volume":"234","author":"P Maciejak","year":"2013","unstructured":"Maciejak, P., Szyndler, J., Turzy\u0144ska, D., Sobolewska, A., Ko\u0142osowska, K., Lehner, M., et al. (2013). The kynurenine pathway: A missing piece in the puzzle of valproate action? Neuroscience, 234, 135\u2013145. doi: 10.1016\/j.neuroscience.2012.12.052 .","journal-title":"Neuroscience"},{"issue":"S1","key":"1091_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/dom.12509","volume":"17","author":"S Masri","year":"2015","unstructured":"Masri, S., Orozco-Solis, R., Aguilar-Arnal, L., Cervantes, M., & Sassone-Corsi, P. (2015). Coupling circadian rhythms of metabolism and chromatin remodelling. Diabetes, Obesity and Metabolism, 17(S1), 17\u201322. doi: 10.1111\/dom.12509 .","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"18","key":"1091_CR35","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1021\/ac101722e","volume":"82","author":"P Masson","year":"2010","unstructured":"Masson, P., Alves, A. C., Ebbels, T. M. D., Nicholson, J. K., & Want, E. J. (2010). Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Analytical Chemistry, 82(18), 7779\u20137786. doi: 10.1021\/ac101722e .","journal-title":"Analytical Chemistry"},{"issue":"6","key":"1091_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1528-1157.1980.tb04310.x","volume":"21","author":"PB Mortensen","year":"1980","unstructured":"Mortensen, P. B., Kplvraa, S., & Christensen, E. (1980). Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia, 21(6), 563\u2013569. doi: 10.1111\/j.1528-1157.1980.tb04310.x .","journal-title":"Epilepsia"},{"issue":"24","key":"1091_CR37","doi-asserted-by":"publisher","first-page":"21767","DOI":"10.1074\/jbc.M110.213298","volume":"286","author":"A Nikiforov","year":"2011","unstructured":"Nikiforov, A., Dolle, C., Niere, M., & Ziegler, M. (2011). Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. Journal of Biological Chemistry, 286(24), 21767\u201321778. doi: 10.1074\/jbc.M110.213298 .","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"1091_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","volume":"43","author":"V Pylv\u00e4nen","year":"2002","unstructured":"Pylv\u00e4nen, V., Knip, M., Pakarinen, A., Kotila, M., Turkka, J., & Isoj\u00e4rvi, J. I. T. (2002). Serum insulin and leptin levels in valproate-associated obesity. Epilepsia, 43(5), 514\u2013517. doi: 10.1046\/j.1528-1157.2002.31501.x .","journal-title":"Epilepsia"},{"issue":"5529","key":"1091_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1126\/science.1060698","volume":"293","author":"J Rutter","year":"2001","unstructured":"Rutter, J., Reick, M., Wu, L., & McKnight, S. (2001). Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science, 293(5529), 510\u2013514. doi: 10.1126\/science.1060698 .","journal-title":"Science"},{"issue":"6","key":"1091_CR40","doi-asserted-by":"publisher","first-page":"C1773","DOI":"10.1152\/ajpcell.00409.2007","volume":"293","author":"HM Said","year":"2007","unstructured":"Said, H. M., Nabokina, S. M., Balamurugan, K., Mohammed, Z. M., Urbina, C., & Kashyap, M. L. (2007). Mechanism of nicotinic acid transport in human liver cells: experiments with HepG2 cells and primary hepatocytes. American Journal of Physiology and Cell Physiology, 293(6), C1773\u2013C1778. doi: 10.1152\/ajpcell.00409.2007 .","journal-title":"American Journal of Physiology and Cell Physiology"},{"key":"1091_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.chroma.2013.08.076","volume":"1311","author":"RM Seifar","year":"2013","unstructured":"Seifar, R. M., Ras, C., Deshmukh, A. T., Bekers, K. M., Suarez-Mendez, C. A., da Cruz, A. L. B., et al. (2013). Quantitative analysis of intracellular coenzymes in Saccharomyces cerevisiae using ion pair reversed phase ultra high performance liquid chromatography tandem mass spectrometry. Journal of Chromatography A, 1311, 115\u2013120. doi: 10.1016\/j.chroma.2013.08.076 .","journal-title":"Journal of Chromatography A"},{"issue":"2","key":"1091_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1271\/bbb.120716","volume":"77","author":"K Shibata","year":"2013","unstructured":"Shibata, K., Kondo, R., Sano, M., & Fukuwatari, T. (2013). Increased conversion of tryptophan to nicotinamide in rats by dietary valproate. Bioscience, Biotechnology, and Biochemistry, 77(2), 295\u2013300. doi: 10.1271\/bbb.120716 .","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"3","key":"1091_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neulet.2005.09.030","volume":"392","author":"A Shimada","year":"2006","unstructured":"Shimada, A., Nakagawa, Y., Morishige, H., Yamamoto, A., & Fujita, T. (2006). Functional characteristics of H+-dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neuroscience Letters, 392(3), 207\u2013212. doi: 10.1016\/j.neulet.2005.09.030 .","journal-title":"Neuroscience Letters"},{"issue":"1","key":"1091_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/taap.1999.8683","volume":"158","author":"M Shin","year":"1999","unstructured":"Shin, M., Ohnishi, M., Iguchi, S., Sano, K., & Umezawa, C. (1999). Peroxisome-proliferator regulates key enzymes of the tryptophan-NAD+ pathway. Toxicology and Applied Pharmacology, 158(1), 71\u201380.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"1091_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","volume":"31","author":"MF Silva","year":"2008","unstructured":"Silva, M. F., Aires, C. C., Luis, P. B., Ruiter, J. P., IJlst, L., Duran, M., et al. (2008). Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. Journal of Inherited Metabolic Disease, 31(2), 205\u2013216. doi: 10.1007\/s10545-008-0841-x .","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"3","key":"1091_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/1078-0432.CCR-10-0738","volume":"17","author":"JM Su","year":"2011","unstructured":"Su, J. M., Li, X. N., Thompson, P., Ou, C. N., Ingle, A. M., Russell, H., et al. (2011). Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children\u2019s oncology group report. Clinical Cancer Research, 17(3), 589\u2013597. doi: 10.1158\/1078-0432.CCR-10-0738 .","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"1091_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.eplepsyres.2012.04.001","volume":"101","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto, Y., Takahashi, Y., Suzuki, E., Mishima, N., Inoue, K., Itoh, K., et al. (2012). Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients. Epilepsy Research, 101(3), 202\u2013209. doi: 10.1016\/j.eplepsyres.2012.04.001 .","journal-title":"Epilepsy Research"},{"issue":"1","key":"1091_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103\u2013141. doi: 10.1016\/j.pharmthera.2012.12.007 .","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"1091_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2014.08.007","volume":"62","author":"ZY Zhang","year":"2015","unstructured":"Zhang, Z. Y., Hong, D., Nam, S. H., Kim, J. M., Paik, Y. H., Joh, J. W., et al. (2015). SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma. Journal of Hepatology, 62(1), 121\u2013130. doi: 10.1016\/j.jhep.2014.08.007 .","journal-title":"Journal of Hepatology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-016-1091-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11306-016-1091-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-016-1091-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:55:06Z","timestamp":1498319706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11306-016-1091-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1007\/s11306-016-1091-9","relation":{},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"type":"print","value":"1573-3882"},{"type":"electronic","value":"1573-3890"}],"subject":[],"published":{"date-parts":[[2016,8]]},"article-number":"142"}}